Effect of Blood Pressure on Cardiovascular Outcomes and R... | NCT06433336

Studies
Effect of Blood Pressure on Cardiovascular Outcomes and Recurrence After Catheter Ablation in Patients With Atrial Fibrillation

NCT06433336

Sponsor

Lanzhou University Second Hospital

Status

Completed

Last Update Posted

May 29, 2024Actual

Enrollment

800Actual

Phase

Not provided

Conditions

Atrial Fibrillation, Persistent
Blood Pressure

Interventions

Not provided

Countries

China

Protocol Section

Identification Module Status Module Sponsor/Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms/Interventions Module Outcomes Module Eligibility Module Contacts/Locations Module References Module IPD Sharing Statement Module

Results Section

Participant Flow Module Baseline Characteristics Module Outcome Measures Module Adverse Events Module More Info Module

Annotation Section

Annotation Module

Document Section

Large Document Module

Derived Section

Miscellaneous Info Module Condition Browse Module Intervention Browse Module

Protocol Section

Identification Module

NCT ID

Results Section

No data available

No data is available for this block.

Annotation Section

No data available

No data is available for this block.

Document Section

No data available

No data is available for this block.

Derived Section

Miscellaneous Info Module

Version Holder

ID	Type	Description	Link
lanzhou university	Other Identifier	lanzhou university second hospital

Status Module

Record Verification Date

May 2024

Overall Recruitment Status or Expanded Access Status

Completed

Last Known Status

Not provided

Delayed Posting

Not provided

Why Stopped

Not provided

Expanded Access Info

Start Date

Jan 1, 2019Actual

Primary Completion Date

May 21, 2024Actual

Completion Date

May 21, 2024Actual

First Submitted Date

May 22, 2024

First Submission Date that Met QC Criteria

May 22, 2024

First Posted Date

May 29, 2024Actual

Results Waived

Not provided

Results First Submitted Date

Not provided

Results First Submitted that Met QC Criteria

Not provided

Results First Posted Date

Not provided

Certification/Extension (aka Delayed Results) First Submitted Date

Not provided

Certification/Extension First Submitted that Passed QC Review

Not provided

Certification/Extension First Posted Date

Not provided

Last Update Submitted Date

May 22, 2024

Last Update Posted Date

May 29, 2024Actual

Sponsor/Collaborators Module

Responsible Party, by Official Title

Xiaowei Zhang, lanzhou university second hospital, Lanzhou University Second HospitalPrincipal Investigator

Lead Sponsor

Lanzhou University Second HospitalOTHER

Collaborators

Not provided

Oversight Module

Has Data Monitoring Committee (DMC)

Not provided

Is FDA Regulated Drug

Is FDA Regulated Device

Is Unapproved Device

Not provided

Pediatric Postmarket Surveillance of a Device Product

Not provided

Product Exported from US

Not provided

FDAAA801 Violation

Not provided

Description Module

Brief Summary

Effect of blood pressure on cardiovascular outcomes and recurrence after catheter ablation in patients with atrial fibrillation

Detailed Description

Not provided

Design Module

Study Type

Observational

Number of References to an Expanded Access Study

Not provided

Expanded Access Types

Not provided

Patient Registry

Yes

Target Follow-Up Duration

1 Year

Phases

Not provided

Interventional Study Design

Allocation

Not provided

Intervention Model

Biospecimen

No data available

No data is available for this block.

Enrollment

800Actual

Arms/Interventions Module

Arm Groups

Label	Type	Description	Intervention Names
Effect of blood pressure on cardiovascular outcomes and recurrence after catheter ablation in patien		Atrial Fibrillation Recurrence Pulmonary Vein Isolation

Interventions

Not provided

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
cardiovascular events	death AMI stroke	1 years

Secondary Outcomes

Not provided

Other Outcomes

Not provided

Eligibility Module

Eligibility Criteria

Inclusion Criteria:

The inclusion criteria were age >18 years and a diagnosis of AF by electrocardiogram during the preceding six months or on admission

Exclusion Criteria:

No follow-up

Accepts Healthy Volunteers

Not provided

Sex

All

Sex/Gender Based

Not provided

Sex/Gender Description

Not provided

Minimum Age

Not provided

Maximum Age

Not provided

Standard Ages

ChildAdultOlder Adult

Study Population

Between February 2019 and December 2024, 800 consecutive patients who had been referred to lanzhou University second Hospital for treatment of AF and underwent successful ablation were assessed

Sampling Method

Probability Sample

Contacts/Locations Module

Central Contacts

Not provided

Overall Officials

Name	Affiliation	Role
xiao wei xiaowei zhang, PHD	Lanzhou University Second Hospital	Principal Investigator

Locations

Facility	Status	City	State	ZIP	Country	Contacts
Lanzhou University Second Hospital		Lanzhou	Gansu	730030	China

Condition Browse Module

MeSH Terms

ID	Term
D001281	Atrial Fibrillation

Ancestor Terms

ID	Term
D001145	Arrhythmias, Cardiac
D006331	Heart Diseases
D002318	Cardiovascular Diseases
D010335	Pathologic Processes

Browse Leaves

Not provided

Browse Branches

Not provided